Literature DB >> 2585016

Fluorouracil, interferon-alpha, and colon cancer: rational pursuit of synergism between antimetabolites and biologicals.

M S Ernstoff, B C Lembersky, J M Kirkwood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2585016     DOI： 10.1200/JCO.1989.7.12.1764

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Haematological effects of interferon-beta-1a (Rebif) therapy in multiple sclerosis.

Authors:  Peter Rieckmann; Paul O'Connor; Gordon S Francis; Graham Wetherill; Enrica Alteri
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

2.  Treatment of advanced pancreatic cancer with 5-fluorouracil, folinic acid and interferon alpha-2A: results of a phase II trial.

Authors:  H Bernhard; E Jäger-Arand; G Bernhard; M Heike; O Klein; J F Riemann; K H Meyer zum Büschenfelde; W Dippold; A Knuth
Journal:  Br J Cancer       Date:  1995-01       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.